Eli Lilly Provides Update On Mounjaro And Zepbound Compounding Litigation; Enters Settlement Requiring Totality Medispa To Make Monetary Payment, Prohibiting Misleading Conduct, And Reporting Adverse Events To FDA
Eli Lilly Provides Update On Mounjaro And Zepbound Compounding Litigation; Enters Settlement Requiring Totality Medispa To Make Monetary Payment, Prohibiting Misleading Conduct, And Reporting Adverse Events To FDA
禮來公司提供有關Mounjaro和Zepbound複合訴訟的最新情況；達成和解，要求Totality Medispa付款，禁止誤導性行爲，並向FDA報告不良事件
Eli Lilly Provides Update On Mounjaro And Zepbound Compounding Litigation; Enters Settlement Requiring Totality Medispa To Make Monetary Payment, Prohibiting Misleading Conduct, And Reporting Adverse Events To FDA
禮來公司提供有關Mounjaro和Zepbound複合訴訟的最新情況；達成和解，要求Totality Medispa付款，禁止誤導性行爲，並向FDA報告不良事件
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。